Relationships between nasal potential difference and respiratory function in adults with cystic fibrosis

This study investigated the relations between nasal transepithelial electric potential difference (PD) and the phenotype and genotype of cystic fibrosis (CF) adult patients. Basal nasal PD was measured in 95 adult CF patients who were classified into three groups of nasal PD (expressed as absolute values) according to the 10th and the 90th percentiles (28.3 and 49.2 mV, respectively), which defined group 1 (nasal PD < or =28.3 mV), group 2 (nasal PD 28.3-49.2 mV) and group 3 (nasal PD > or =49.2 mV). Patients from group 1 had a higher forced vital capacity (FVC) than patients from groups 2 and 3 (76.5+/-22.4 versus 57.4+/-21.2 and 55.7+/-21.1% predicted, respectively, p<0.05) and a higher forced expiratory volume in one second (FEV1) (69.3+/-24.0 versus 42.5+/-22.4 and 42.2+/-21.4% pred, respectively, p<0.01). Among patients with severe mutations (deltaF508 homozygotes, or one deltaF508 mutation plus another "severe" mutation, or two "severe" mutations), patients from group 1 had a higher FVC, FEV1 and arterial oxygen tension than patients from groups 2 and 3 (p<0.05 for each comparison). The results show that in adult cystic fibrosis patients a normal basal nasal potential difference is related to milder respiratory disease, irrespective of the severity of the genotype.

This article has been cited by other articles:

				A. M. Trzcinska-Daneluti, D. Ly, L. Huynh, C. Jiang, C. Fladd, and D. Rotin High-content Functional Screen to Identify Proteins that Correct F508del-CFTR Function Mol. Cell. Proteomics, April 1, 2009; 8(4): 780 - 790. [Abstract] [Full Text] [PDF]

				M. M. Myerburg, M. B. Butterworth, E. E. McKenna, K. W. Peters, R. A. Frizzell, T. R. Kleyman, and J. M. Pilewski Airway Surface Liquid Volume Regulates ENaC by Altering the Serine Protease-Protease Inhibitor Balance: A MECHANISM FOR SODIUM HYPERABSORPTION IN CYSTIC FIBROSIS J. Biol. Chem., September 22, 2006; 281(38): 27942 - 27949. [Abstract] [Full Text] [PDF]

				F. Van Goor, K. S. Straley, D. Cao, J. Gonzalez, S. Hadida, A. Hazlewood, J. Joubran, T. Knapp, L. R. Makings, M. Miller, et al. Rescue of {Delta}F508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1117 - L1130. [Abstract] [Full Text] [PDF]

				N A Jarad, S Higgs, T Jeffcote, and K Giles Factors associated with reduced FEV1 in adult patients with cystic fibrosis in a relatively affluent area Chronic Respiratory Disease, July 1, 2005; 2(3): 133 - 137. [Abstract] [PDF]

				I Fajac, D Hubert, D Guillemot, I Honore, T Bienvenu, F Volter, J Dall'Ava-Santucci, and D J Dusser Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients Thorax, November 1, 2004; 59(11): 971 - 976. [Abstract] [Full Text] [PDF]

				D. B. Salinas, N. Pedemonte, C. Muanprasat, W. F. Finkbeiner, D. W. Nielson, and A. S. Verkman CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L936 - L943. [Abstract] [Full Text] [PDF]

				H. L. Wallace, P. M. Barker, and K. W. Southern Nasal Airway Ion Transport and Lung Function in Young People with Cystic Fibrosis Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 594 - 600. [Abstract] [Full Text] [PDF]

				Z. Bebok, A. Tousson, L. M. Schwiebert, and C. J. Venglarik Improved oxygenation promotes CFTR maturation and trafficking in MDCK monolayers Am J Physiol Cell Physiol, January 1, 2001; 280(1): C135 - C145. [Abstract] [Full Text] [PDF]